(2E)-1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one - CAS 13351-10-5
Catalog: |
BB055808 |
Product Name: |
(2E)-1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one |
CAS: |
13351-10-5 |
Synonyms: |
C16H14O4 |
IUPAC Name: | (E)-1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one |
Description: | (2E)-1-(2,4-dihydroxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one (cas# 13351-10-5) is a useful research chemical. |
Molecular Weight: | 270.28 |
Molecular Formula: | C16H14O4 |
Canonical SMILES: | COC1=CC=C(C=C1)C=CC(=O)C2=C(C=C(C=C2)O)O |
InChI: | InChI=1S/C16H14O4/c1-20-13-6-2-11(3-7-13)4-9-15(18)14-8-5-12(17)10-16(14)19/h2-10,17,19H,1H3/b9-4+ |
InChI Key: | ADRQFDIWPRFKSP-RUDMXATFSA-N |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P317, P330, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2022015740-A1 | Compositions and methods of treating ups-associated diseases | 20200713 |
CN-106166145-A | The new application of chalcone compounds | 20150521 |
US-2014350304-A1 | Composition for treating diabetes and metabolic diseases and a preparation method thereof | 20110810 |
US-9085520-B2 | Composition for treating diabetes and metabolic diseases and a preparation method thereof | 20110810 |
WO-2013022951-A1 | Composition for treating diabetes and metabolic diseases and a preparation method thereof | 20110810 |
US-2007265317-A1 | Modified chalcone compounds as antimitotic agents | 20060510 |
US-2010222380-A1 | Modified Chalcone Compounds as Antimitotic Agents | 20060510 |
US-7714025-B2 | Modified chalcone compounds as antimitotic agents | 20060510 |
EP-1888174-B1 | Use of chalcones for the treatment of viral disorders | 20050524 |
US-2006270614-A1 | Use of chalcones for the treatment of viral disorders | 20050524 |
PMID | Publication Date | Title | Journal |
22608392 | 20120615 | Synthesis of chalcone derivatives as potential anti-diabetic agents | Bioorganic & medicinal chemistry letters |
22112540 | 20120101 | Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein | Bioorganic & medicinal chemistry |
22177409 | 20120101 | Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines | Bioorganic & medicinal chemistry |
19807106 | 20091112 | 7-Hydroxy-benzopyran-4-one derivatives: a novel pharmacophore of peroxisome proliferator-activated receptor alpha and -gamma (PPARalpha and gamma) dual agonists | Journal of medicinal chemistry |
18603336 | 20090501 | Synthesis of (+/-)Abyssinone I and related compounds: Their anti-oxidant and cytotoxic activities | European journal of medicinal chemistry |
17502148 | 20070715 | Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore | Bioorganic & medicinal chemistry |
17125223 | 20061101 | Protein tyrosine phosphatase-1B inhibitory activity of isoprenylated flavonoids isolated from Erythrina mildbraedii | Journal of natural products |
15225696 | 20040802 | A convenient and biogenetic type synthesis of few naturally occurring chromeno dihydrochalcones and their in vitro antileishmanial activity | Bioorganic & medicinal chemistry letters |
Complexity: | 344 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 1 |
Exact Mass: | 270.08920892 |
Formal Charge: | 0 |
Heavy Atom Count: | 20 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 270.08920892 |
Rotatable Bond Count: | 4 |
Topological Polar Surface Area: | 66.8Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 3.7 |
-
Catalog: BB055501
(-)-Camphenilone
Detail
-
Catalog: BB058457
((R)-5-Oxopyrrolidine-2-carbonyl)-L-glutamic Acid
Detail
-
Catalog: BB056712
((S)-Oxopyrrolidine-2-carbonyl)-L-cysteine
Detail
-
Catalog: BB056058
(+)-(1R,2R,5R)--Ethyl [(2-Hydroxypinan-3-ylene)amino]acetate
Detail
-
Catalog: BB064047
(-)-Huperzine A-d7 major (>90%)
Detail
-
Catalog: BB069468
(+)-(S,S,S)-Ciramadol
Detail
-
Catalog: BB055796
(-)-(1S,2R)-1,2-Dihydro-1,2-naphthalenediol
Detail
-
Catalog: BB069213
(-)-(18-Crown-6)-2,3,11,12-tetracarboxamide
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
-
[80935-77-9]
2,6-Naphthyridin-1(2H)-one
-
[91054-33-0]
2-acetylbenzenecarbonitrile
-
[1415761-37-3]
5,8-Dibromo-1,3-diaza-2,6,7-trithia-2H-trindene
-
[1388152-02-0]
1,2-Cyclopentanediol, 3-amino-5-[(phosphonooxy)methy]-, ammonium salt (1:2), (1R,2S,3R,5R)-
-
[6315-52-2]
Ethylene di(p-toluenesulfonate)
-
[616-76-2]
5-Formylsalicylic acid
INDUSTRY LEADERS TRUST OUR PRODUCTS